Last reviewed · How we verify
Placebo Jelly
Placebo Jelly is an inert formulation used as a control comparator in clinical trials to establish the efficacy of active pharmaceutical agents through blinded comparison.
At a glance
| Generic name | Placebo Jelly |
|---|---|
| Also known as | Lubricating Gel, Vaginal Lubricant |
| Sponsor | University of South Florida |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
As a placebo, this jelly formulation contains no active pharmaceutical ingredient and works through the placebo effect—the therapeutic benefit derived from patient expectation and the clinical trial context rather than pharmacological action. It serves as the control arm in phase 3 trials to distinguish genuine drug efficacy from baseline improvement, natural disease progression, or psychological factors.
Approved indications
Common side effects
Key clinical trials
- Analgesic Efficacy and Safety of Topical VMD-3866 Gel in Management of Pain Induced by Chemotherapy (CIPN) (PHASE2)
- Effect of MI Paste Plus™ on Streptococcus Mutans and White Spot Lesions in Fixed Orthodontics (NA)
- FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM) (PHASE2)
- Safety and Effect on Pain and Function According to RAPID-3 of IHL-675A in Patients With Rheumatoid Arthritis (PHASE2)
- Effects of Focal Extracorporeal Shock Wave Therapy in the Treatment of Temporomandibular Disorders of Muscular Origin (NA)
- Testing the Addition of Darolutamide to Hormonal Therapy (Androgen Deprivation Therapy [ADT]) After Surgery for Men With High-Risk Prostate Cancer, The ERADICATE Study (PHASE3)
- Effectiveness of Topical Menthol as A Cooling Method During Exercise in A Recreational Runner Population (PHASE2, PHASE3)
- Effects of Pazopanib on Hereditary Hemorrhagic Telangiectasia Related Epistaxis and Anemia (Paz) (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo Jelly CI brief — competitive landscape report
- Placebo Jelly updates RSS · CI watch RSS
- University of South Florida portfolio CI